JLK Inc (322510) - Total Liabilities
Based on the latest financial reports, JLK Inc (322510) has total liabilities worth ₩33.18 Billion KRW (≈ $22.49 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
JLK Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how JLK Inc's total liabilities have evolved over time, based on quarterly financial data. See JLK Inc (322510) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
JLK Inc Competitors by Total Liabilities
The table below lists competitors of JLK Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korea Cast Pip
KO:000970
|
Korea | ₩68.47 Billion |
|
Fidelix Co. Ltd
KQ:032580
|
Korea | ₩11.13 Billion |
|
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
|
USA | $22.73 Million |
|
Ensari Deri Gida Sanayi ve Ticaret AS
IS:ENSRI
|
Turkey | TL770.87 Million |
|
Sambo Corrugated Board Co. Ltd
KQ:023600
|
Korea | ₩186.73 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩22.80 Billion |
|
Panasonic Manufacture Malaysia
KLSE:3719
|
Malaysia | RM94.72 Million |
|
Dekuple
PA:DKUPL
|
France | €204.20 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down JLK Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 322510 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how JLK Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for JLK Inc (2017–2024)
The table below shows the annual total liabilities of JLK Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩25.28 Billion ≈ $17.13 Million |
+17.95% |
| 2023-12-31 | ₩21.43 Billion ≈ $14.52 Million |
+8.71% |
| 2022-12-31 | ₩19.71 Billion ≈ $13.36 Million |
+20.46% |
| 2021-12-31 | ₩16.36 Billion ≈ $11.09 Million |
+3.02% |
| 2020-12-31 | ₩15.88 Billion ≈ $10.76 Million |
+562.49% |
| 2019-12-31 | ₩2.40 Billion ≈ $1.62 Million |
-27.95% |
| 2018-12-31 | ₩3.33 Billion ≈ $2.26 Million |
-76.05% |
| 2017-12-31 | ₩13.90 Billion ≈ $9.42 Million |
-- |
About JLK Inc
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatme… Read more